Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20860904rdf:typepubmed:Citationlld:pubmed
pubmed-article:20860904lifeskim:mentionsumls-concept:C0239307lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C1337242lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C0058928lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C1518527lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C0454664lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:20860904lifeskim:mentionsumls-concept:C1655045lld:lifeskim
pubmed-article:20860904pubmed:issue3lld:pubmed
pubmed-article:20860904pubmed:dateCreated2010-9-23lld:pubmed
pubmed-article:20860904pubmed:abstractTextThe pan-European ECHO observational study evaluated cinacalcet in adult dialysis patients with secondary hyperparathyroidism (SHPT) in "real-world" clinical practice. A sub-analysis compared data for 7 European countries/country clusters: Austria, CEE (Czech Republic and Slovakia), France, Italy, Netherlands, Nordics (Denmark, Finland, Norway, and Sweden), and the UK/Ireland.lld:pubmed
pubmed-article:20860904pubmed:languageenglld:pubmed
pubmed-article:20860904pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20860904pubmed:citationSubsetIMlld:pubmed
pubmed-article:20860904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20860904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20860904pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20860904pubmed:statusMEDLINElld:pubmed
pubmed-article:20860904pubmed:monthSeplld:pubmed
pubmed-article:20860904pubmed:issn0301-0430lld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:REEDW BWBlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:OzFFlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:JacobsonS HSHlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:FouqueDDlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:UreñaPPlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:MalbertiFFlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:SahaHHlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:RixMMlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:VervloetMMlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:DehmelBBlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:PetavyFFlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:AshmanNNlld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:ZittEElld:pubmed
pubmed-article:20860904pubmed:authorpubmed-author:BencovaVVlld:pubmed
pubmed-article:20860904pubmed:issnTypePrintlld:pubmed
pubmed-article:20860904pubmed:volume74lld:pubmed
pubmed-article:20860904pubmed:ownerNLMlld:pubmed
pubmed-article:20860904pubmed:authorsCompleteYlld:pubmed
pubmed-article:20860904pubmed:pagination198-208lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:meshHeadingpubmed-meshheading:20860904...lld:pubmed
pubmed-article:20860904pubmed:year2010lld:pubmed
pubmed-article:20860904pubmed:articleTitle"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study.lld:pubmed
pubmed-article:20860904pubmed:affiliationVU Medisch Centrum, Amsterdam, The Netherlands. M.Vervloet@vumc.nllld:pubmed
pubmed-article:20860904pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20860904pubmed:publicationTypeMulticenter Studylld:pubmed